selected scholarly activity
-
chapters
- Hematologic Manifestations of End-Organ Failure. 2305-2311. 2022
- Chapter 153 Hematologic Manifestations of Liver Disease. 2238-2243. 2018
- Hematologic Manifestations of Liver Disease. 2238-2243. 2018
- Hematologic Manifestations of Liver Disease. 2238-2243. 2017
-
conferences
- The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab. Blood. 2157-2158. 2022
- Values and Preferences Towards Antithrombotic Therapy in Patients with Myeloproliferative Neoplasms: A Qualitative Study. Blood. 13280-13281. 2022
- Fitness Assessment of Elderly Patients with AML and Outcomes. Blood. 3379-3379. 2021
- Cardiovascular events among recipients of hematopoietic stem cell transplantation. European Heart Journal. ehab724.2876. 2021
- Cardiovascular events among recipients of hematopoietic stem cell transplantation. European Heart Journal. 2876-2876. 2021
- AML-303: Systematic Review of Frailty Assessment Tools for Elderly Patients with Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia. S200-S200. 2020
- Systematic Review of Frailty Assessment Tools for Elderly Patients with Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia. S200-S200. 2020
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis. Vox Sanguinis. 505-516. 2019
- Reducing Unnecessary Blood Tests in the Critically Ill (RUBIC): A Multi-Center Prospective Audit. American Journal of Respiratory and Critical Care Medicine. 2019
- Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review. Blood. 4273-4273. 2018
- The Predictive Value of Intracellular Imatinib Levels in Chronic Myeloid Leukemia. Blood. 4250-4250. 2018
- RESUMPTION OF ANTICOAGULANT THERAPY AFTER ANTICOAGULANT-RELATED GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S220-S220. 2018
- The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes. Blood. 2017
- Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome. Arthritis & Rheumatology. 2017
- THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome. Annals of the Rheumatic Diseases. 2017
- Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries. Blood. 3079-3079. 2016
- Failure to Achieve Early Molecular Milestone within 3 Months Is Associated with Higher Risk of Relapse and Worse Survival after Allogeneic Hematopoietic Stem Cell Transplant for Chronic Myeloid Leukemia Patients, Especially after Tyrosine Kinase Inhibitor Failure. Blood. 1907-1907. 2016
- Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis. Blood. 3821-3821. 2016
- Audit of Provincial IVIG Request Forms and Efficacy Documentation in Four Tertiary Care Centres in Canada. Transfusion. 177A-178A. 2016
- A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes. Blood. 4446-4446. 2015
- Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review. Blood. 5252-5252. 2015
- Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis. Blood. 4030-4030. 2015
- Systematic Review of Therapeutic Plasma Exchange for the Treatment of Catastrophic Antiphospholipid Antibody Syndrome. Journal of Rheumatology. 1269-1269. 2015
- Hemodialysis for the treatment of dabigatran-associated bleeding: a systematic review of the literature. Journal of Thrombosis and Haemostasis. 119-119. 2015
- Cardiovascular events in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 2015
- FATAL BLEEDING, CASE-FATALITY RATE OF MAJOR BLEEDING AND ALL-CAUSE MORTALITY IN PATIENTS TAKING TARGET-SPECIFIC ORAL ANTICOAGULANT, A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal of the American College of Cardiology. A2052-A2052. 2015
- A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia. Blood. 2821-2821. 2014
- Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure. Blood. 4554-4554. 2014
- CLINICAL UTILITY OF 1:1 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) MIXING STUDY USING A LUPUS INSENSITIVE REAGENT.. American Journal of Hematology. E23-E24. 2014
- PTEN in zebrafish gastrulation. Developmental Biology. 440-440. 2006
-
journal articles
- ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.. Acta Haematologica. 1-7. 2025
- "Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype": comment from Al Sharif et al.. Journal of Thrombosis and Haemostasis. 23:1123-1126. 2025
- A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.. Frontiers in Medicine. 12:1548590. 2025
- In EPAs we trust, is quality and safety a must? A cross-specialty analysis of entrustable professional activity guides. Medical Teacher. 47:1-9. 2025
- Inflammation in Myeloproliferative Philadelphia Chromosome Negative Neoplasms- Relationship with Biomarkers of Disease Activity. Blood. 144:6631-6632. 2024
- The Role of JAK2 Allele Burden on Muscle Strength and Physical Functioning in Patients with Myeloproliferative Neoplasm: A Systematic Review and Prospective Cohort Analysis. Blood. 144:6672-6672. 2024
- The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.. Cancers. 16:3182. 2024
- How a Canadian federal organization integrated synoptic reporting and quality improvement tools to drive a national learning health system in cancer surgery. Healthcare Management Forum. 37:309-319. 2024
- A Canadian survey of perceptions and practices related to ordering of blood tests in the intensive care unit. Canadian Journal of Anaesthesia. 71:1137-1144. 2024
- Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study. Transfusion Medicine. 34:268-277. 2024
- Implementation and evaluation of a national quality improvement initiative in cancer surgery. BMJ quality improvement reports. 13:e002759-e002759. 2024
- Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia. 38:570-578. 2024
- Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors. Current Cardiology Reports. 25:941-958. 2023
- Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation. 58:478-490. 2023
- Optimizing Cancer Survivorship Care: Examination of Factors Associated with Transition to Primary Care. Current Oncology. 30:2743-2750. 2023
- A Survey of Patient Experience in CML: American and Canadian Perspectives. Patient Preference and Adherence. Volume 17:331-347. 2023
- Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. The Lancet. 401:269-280. 2023
-
Perioperative management of myeloproliferative neoplasms: A
pan‐Canadian physician survey and international expert opinion. American Journal of Hematology. 97:E466-E469. 2022 - The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada. PharmacoEconomics (Auckland). 40:917-928. 2022
- Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study. Leukemia Research. 113:106788-106788. 2022
- Identification and Adjudication of Adverse Events Following Rectal Cancer Surgery: Observational Case Series in a Region of Ontario, Canada. Annals of Surgical Oncology. 29:1182-1191. 2022
- ASO Visual Abstract: Identification and Adjudication of Adverse Events following Rectal Cancer Surgery—Observational Case Series in a Region of Ontario, Canada. Annals of Surgical Oncology. 28:672-673. 2021
- Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation. Current Oncology Reports. 23:113. 2021
- Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’. Heart. 107:1680.2-1681. 2021
- A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre. Gynecologic Oncology. 161:236-243. 2021
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease. Heart. 107:667-673. 2021
- Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study. Blood. 136:9-10. 2020
- Elucidating Barriers to Advance Care Planning in Malignant Hematology Clinics: A Single Centre Experience in Ontario, Canada. Blood. 136:17-18. 2020
- Increased Health Resource Utilization with the Introduction of Matrix for First-Line Treatment of Primary Central Nervous System Lymphoma. Blood. 136:40-41. 2020
- Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. Journal of Intensive Care Medicine. 35:1074-1079. 2020
- Investigation and management of erythrocytosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E913-E918. 2020
- Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group. JCO Oncology Practice. 16:351-359. 2020
- The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia. Leukemia Research. 88:106285-106285. 2020
- Strategies for eliciting and synthesizing evidence for guidelines in rare diseases. BMC Medical Research Methodology. 19:67. 2019
- Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol. BMJ Open. 9:e030092-e030092. 2019
- PS1466 CYTOREDUCTION FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: A SYSTEMATIC REVIEW. HemaSphere. 3:676-676. 2019
- Engaging residents to choose wisely: Resident Doctors of Canada resource stewardship recommendations. Canadian Medical Education Journal. 10:e39-55. 2019
- Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis. Thrombosis Research. 175:102-109. 2019
- Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era. Leukemia Research. 73:67-75. 2018
- Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice. Thrombosis Research. 167:6-8. 2018
- The real-world outcomes of treating Polycythemia Vera: Physician adherence to treatment guidelines. Leukemia Research. 70:62-66. 2018
- Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis. Transfusion and Apheresis Science. 57:215-221. 2018
- McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 16:1656-1664. 2018
- Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis. Thrombosis Research. 160:97-104. 2017
- Assessing physician awareness of the Choosing Wisely Canada recommendations. Canadian Journal of General Internal Medicine. 12:17-22. 2017
- Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia. ACP journal club. 167:170-170. 2017
- Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis. Blood Advances. 1:772-778. 2017
-
Audit of provincial
IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres. Transfusion Medicine. 27:122-131. 2017 - A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature. BMC Blood Disorders. 16:17. 2016
- CARDIOVASCULAR COMPLICATIONS OF IBRUTINIB: A SYSTEMATIC REVIEW AND META-ANALYSIS. Canadian Journal of Cardiology. 32:S272-S272. 2016
- Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thrombosis and Haemostasis. 116:879-890. 2016
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 128:138-140. 2016
- Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis. Leukemia and Lymphoma. 57:1300-1310. 2016
-
Gender and
BCR ‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia. European Journal of Haematology. 96:360-366. 2016 - Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation. CANADIAN MEDICAL ASSOCIATION JOURNAL. 188:361-362. 2016
- Best practices in the differential diagnosis and reporting of acute transfusion reactions. International Journal of Clinical Transfusion Medicine. 4:1-1. 2016
- A proposed solution to a urological tightrope walk: The challenge of transition of spina bifida patients from pediatric to adult care in Ontario. Journal of the Canadian Urological Association. 10:306-306. 2016
- Appendix for: "A proposed solution to a urological tightrope walk: The challenge of transition of spina bifida patients from pediatric to adult care in Ontario"n. Journal of the Canadian Urological Association. 10:340-340. 2016
- A systematic review of definitions and reporting of bleeding outcome measures in haemophilia. Haemophilia. 21:731-735. 2015
- Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thrombosis and Haemostasis. 113:1193-1202. 2015
- Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials. Journal of Thrombosis and Haemostasis. 13:2012-2020. 2015
- Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review. Journal of Thrombosis and Haemostasis. 13:1790-1798. 2015
- Cardiovascular events in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 33:7056-7056. 2015
- The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments. Annals of Hematology. 94:541-545. 2015
- Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. Thrombosis and Haemostasis. 114:819-825. 2015
- Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. Blood. 124:2799-2799. 2014
- Chills and limb pain following administration of low‐molecular‐weight heparin for treatment of acute venous thromboembolism. American Journal of Hematology. 86:603-606. 2011